SG11201705397WA - Nisin-based compounds and use thereof in the treatment of bacterial infections - Google Patents
Nisin-based compounds and use thereof in the treatment of bacterial infectionsInfo
- Publication number
- SG11201705397WA SG11201705397WA SG11201705397WA SG11201705397WA SG11201705397WA SG 11201705397W A SG11201705397W A SG 11201705397WA SG 11201705397W A SG11201705397W A SG 11201705397WA SG 11201705397W A SG11201705397W A SG 11201705397WA SG 11201705397W A SG11201705397W A SG 11201705397WA
- Authority
- SG
- Singapore
- Prior art keywords
- nisin
- treatment
- based compounds
- bacterial infections
- infections
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 title 1
- 108010053775 Nisin Proteins 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000004309 nisin Substances 0.000 title 1
- 235000010297 nisin Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2014152 | 2015-01-19 | ||
| NL2014670 | 2015-04-20 | ||
| PCT/EP2016/050827 WO2016116379A1 (en) | 2015-01-19 | 2016-01-15 | Nisin-based compounds and use thereof in the treatment of bacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705397WA true SG11201705397WA (en) | 2017-08-30 |
Family
ID=55273206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705397WA SG11201705397WA (en) | 2015-01-19 | 2016-01-15 | Nisin-based compounds and use thereof in the treatment of bacterial infections |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170362283A1 (en) |
| EP (1) | EP3247379A1 (en) |
| JP (1) | JP2018505871A (en) |
| KR (1) | KR20170102356A (en) |
| CN (1) | CN107108702A (en) |
| AU (1) | AU2016208702A1 (en) |
| BR (1) | BR112017014823A2 (en) |
| CA (1) | CA2972836A1 (en) |
| IL (1) | IL253418A0 (en) |
| MX (1) | MX2017009213A (en) |
| SG (1) | SG11201705397WA (en) |
| WO (1) | WO2016116379A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109627301B (en) * | 2019-02-18 | 2022-08-05 | 浙江新银象生物工程有限公司 | Development and application of Nisin solid stabilizer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2356016T3 (en) * | 2006-03-09 | 2011-04-04 | Cambridge Enterprise Limited | NEW ANTIBIOTIC COMPOSITIONS. |
| AR073014A1 (en) * | 2008-08-12 | 2010-10-06 | Dsm Ip Assets Bv | NISINA LIQUID COMPOSITIONS |
| WO2010058238A1 (en) * | 2008-11-24 | 2010-05-27 | Sentinella Pharmaceuticals, Inc. ("Sentinella") | Lantibiotic carboxyamide derivatives with enhanced antibacterial activity |
| US9975930B2 (en) * | 2012-11-30 | 2018-05-22 | Naicons S.R.L. | Lantibiotic derivatives and process for their preparation |
-
2016
- 2016-01-15 CN CN201680006212.8A patent/CN107108702A/en active Pending
- 2016-01-15 WO PCT/EP2016/050827 patent/WO2016116379A1/en active Application Filing
- 2016-01-15 BR BR112017014823A patent/BR112017014823A2/en not_active Application Discontinuation
- 2016-01-15 MX MX2017009213A patent/MX2017009213A/en unknown
- 2016-01-15 CA CA2972836A patent/CA2972836A1/en not_active Abandoned
- 2016-01-15 US US15/543,660 patent/US20170362283A1/en not_active Abandoned
- 2016-01-15 KR KR1020177022438A patent/KR20170102356A/en unknown
- 2016-01-15 JP JP2017537955A patent/JP2018505871A/en active Pending
- 2016-01-15 EP EP16702338.1A patent/EP3247379A1/en not_active Withdrawn
- 2016-01-15 SG SG11201705397WA patent/SG11201705397WA/en unknown
- 2016-01-15 AU AU2016208702A patent/AU2016208702A1/en not_active Abandoned
-
2017
- 2017-07-11 IL IL253418A patent/IL253418A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017014823A2 (en) | 2018-01-09 |
| EP3247379A1 (en) | 2017-11-29 |
| IL253418A0 (en) | 2017-09-28 |
| US20170362283A1 (en) | 2017-12-21 |
| WO2016116379A1 (en) | 2016-07-28 |
| MX2017009213A (en) | 2017-11-01 |
| JP2018505871A (en) | 2018-03-01 |
| CN107108702A (en) | 2017-08-29 |
| AU2016208702A1 (en) | 2017-07-20 |
| KR20170102356A (en) | 2017-09-08 |
| CA2972836A1 (en) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3325473A4 (en) | Compounds and uses thereof in the treatment of cancers and other medical conditions | |
| ZA201706348B (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections | |
| GB2554629B (en) | Prevention and treatment of microbial infections | |
| EP3390357A4 (en) | Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections | |
| IL271863B (en) | Compounds and use thereof for the treatment of microbial infections | |
| IL268210A (en) | Use of gaboxadol in the treatment of tinnitus | |
| IL264232A (en) | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections | |
| PT3102218T (en) | Treatment of topical and systemic bacterial infections | |
| HK1243951A1 (en) | Antimicrobial combinations and their use in the treatment of microbial infection | |
| LT3405213T (en) | Bacterial ghosts for use in the treatment of cancer | |
| ZA201901963B (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections | |
| PT3285787T (en) | Treatment of bacterial infections in aquaculture | |
| HK1244791A1 (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections | |
| ZA201608607B (en) | Novel fluoroquinolones and use thereof to treat bacterial infections | |
| IL253418A0 (en) | Nisin-based compounds and use thereof in the treatment of bacterial infections | |
| PT2862576T (en) | Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis | |
| ZA201802201B (en) | Novel formulation and treatment methods | |
| GB2558090B (en) | Prevention and treatment for microbial infections | |
| RS59653B1 (en) | Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections | |
| AU2016905362A0 (en) | Compounds and use thereof in methods of treatment | |
| GB201519483D0 (en) | Prevention and treatment of microbial infections | |
| GB201518252D0 (en) | Prevention and treatment of microbial infections | |
| GB201513047D0 (en) | Prevention and treatment of microbial infections | |
| GB201511576D0 (en) | Prevention and treatment of microbial infections | |
| GB201509654D0 (en) | Prevention and treatment of microbial infections |